Detalhe da pesquisa
1.
Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody Titer.
Transpl Int
; 36: 10844, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056357
2.
Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study.
Transpl Int
; 36: 11212, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680645
3.
A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome.
Eur Respir J
; 58(5)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016620
4.
Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR).
Am J Transplant
; 19(3): 894-906, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30582270
5.
De novo posttransplant membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient.
Am J Transplant
; 22(12): 3188-3189, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35959598
6.
C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports.
Eur Respir J
; 55(4)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079639
7.
Ketosis prone diabetes presenting as fulminant type 1 diabetes.
Pan Afr Med J
; 31: 38, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30918564
8.
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide.
Bone Marrow Transplant
; 53(8): 1044-1047, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29391525